John J. Lupica - 01 Jul 2025 Form 4 Insider Report for Chubb Ltd (CB)

Signature
/s/ Samantha Froud, Attorney-in-Fact
Issuer symbol
CB
Transactions as of
01 Jul 2025
Transactions value $
-$1,447,785
Form type
4
Filing time
03 Jul 2025, 14:33:19 UTC
Previous filing
19 May 2025
Next filing
29 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lupica John J Vice Chrm, Chubb Group* THE CHUBB BUILDING, 17 WOODBOURNE AVENUE, HAMILTON, BERMUDA /s/ Samantha Froud, Attorney-in-Fact 03 Jul 2025 0001527836

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CB Common Shares Options Exercise $344K +2.91K +3.1% $118.39 96.7K 01 Jul 2025 Direct F1
transaction CB Common Shares Sale -$843K -2.91K -3.01% $290.07 93.8K 01 Jul 2025 Direct F1, F2
transaction CB Common Shares Sale -$756K -2.61K -2.78% $290.04 91.2K 01 Jul 2025 Direct F1, F3
transaction CB Common Shares Tax liability -$193K -666 -0.73% $289.59 90.5K 01 Jul 2025 Direct F4
holding CB Common Shares 78.7K 01 Jul 2025 By Trust for Wife
holding CB Common Shares 10K 01 Jul 2025 By Trust for Descendants

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CB Options to Acquire Common Shares Options Exercise $0 -2.91K -10.93% $0.00 23.7K 01 Jul 2025 Common Shares 2.91K $118.39 Direct F5
holding CB Options to Acquire Common Shares 163K 01 Jul 2025 Common Shares Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The options were exercised and the shares were sold in compliance with a qualified selling plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, on March 19, 2025.
F2 The Common Shares reported herein as being sold were sold at a range of between $290.00 and $290.31 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
F3 The Common Shares reported herein as being sold were sold at a range of between $290.00 and $290.36 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
F4 Common Shares being withheld in order to pay tax liability.
F5 Options vested as follows: 1/3 on February 25, 2017, 1/3 on February 25, 2018 and 1/3 on February 25, 2019.
F6 Total includes previously reported options from other tranches with different exercise prices, vesting and expiration dates.

Remarks:

*and Executive Chairman, North America Insurance